U.S. Clinical Nutrition Market - Industry Outlook & Forecast 2022-2027

243 pages

56 tables

143 charts

1 region

1 countries

25 company

6 segments

Purchase Options

$3995.00
$4495.00
$5495.00
$2000.00

Have a question?

Please get in touch with our team in case of any queries

+1-312-235-2040

THE U.S. CLINICAL NUTRITION MARKET SIZE WAS VALUED AT USD 12.07 BILLION IN 2021 AND IS EXPECTED TO REACH USD 16.63 BILLION BY 2027, GROWING AT A CAGR OF 5.49% DURING THE FORECAST PERIOD

The U.S. Clinical Nutrition Market Size, Share, and Growth Forecast by: 

  • Products: Powder, Liquid, and Semi-Solid
  • Route of Administration: Oral, Enteral Nutrition, and Parenteral Nutrition
  • Age Group: Infant & Toddlers, Children and Teenagers, Adults, and Geriatric
  • Application: Malnutrition, Metabolic Disorders, Gastrointestinal disorders (GI), Cancer, and Others
  • Distribution Channels: Institutional Sales Channels, Supermarkets and Hypermarkets, Pharmacies and Drug Stores, Specialty Stores, Online Channels, and Others
  • End-Users: Hospitals, Individuals, Home care, and Long-term care facilities

Industry Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share, & Forecast 2022-2027

Customize this Report

This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize

U.S. CLINICAL NUTRITION MARKET REPORT SCOPE

REPORT ATTRIBUTEDETAILS
Market Size (2027)USD 16.63 Billion
Market Size (2021)USD 12.07 Billion
CAGR (2021-2027)5.49%
Base Year2021
Forecast Year2022-2027
Market SegmentsProducts, Route of Administration, Age Group, Application, Distribution Channels, and End-Users
KEY VENDORSAbbott, B. Braun Melsungen Ag., Baxter, Danone, Fresenius Kabi, Nestle, Perrigo Company, and Reckitt Benckiser Group
Interested in this Report?

Download a Sample!

The U.S. clinical nutrition market is expected to grow at a CAGR of 5.49% from 2021 to 2027 and is expected to reach USD 16.63 billion by 2027  from USD 12.07 billion in 2021. The innovation in personalized and targeted clinical nutrition solutions delivers new industry growth opportunities in the U.S. clinical nutrition market. The personalization and targeted solution approach stand with specific formulations that fulfill the need for nutritional support for patients suffering from chronic diseases and associated illnesses. In addition, the COVID-19 pandemic positively influenced the innovation in targeted and personalized clinical nutrition solutions. On another side, the increasing birth rate and the rising demand for milk-based nutritional support products by infants and toddler gives new aspects for vendors in the U.S. clinical nutrition market.

Clinical nutrition, known as medical nutrition, is the practice of analyzing and identifying whether an individual is consuming an adequate amount of nutrients for health. It can also be defined as the study of an overall analysis relationship between ingested meals and the well-being of a person's body. Clinical nutrition prioritizes the management of nutritional adjustment and helps diagnose and prevent nutritional level changes in the human body suffering from chronic conditions.

The U.S. government implements a tremendous breadth and depth of initiatives relevant to the country's nutrition level. So, the increasing government initiatives to improve the country's nutritional health and the rising concern about food insecurity across US families are expected to drive significant U.S. clinical nutrition market growth. In addition, the increasing geriatric population and chronic disease prevalence are constantly fueling industry growth. Obesity, hypertension, gastrointestinal disorders, CVD, and other primary health conditions primely accelerate the country's malnutrition rate, creating a high demand for clinical nutrition. However, there are some limitations to the industry growth, like potential side-effects associated with clinical nutrition and challenges in enteral nutrition deliveries, pediatric ICU patients, and more, hampering the industry growth.

MARKET TRENDS & DRIVERS

Increasing Demand for the Personalized and Targeted Clinical Nutrition
Personalized clinical nutrition is one of the trending approaches in clinical nutrition to fulfill the nutritional demand of every individual patient suffering from specific conditions. The targeted nutrition innovations deliver promising opportunities in medical practices and consumer and food production companies. Innovation in targeted and personalized solutions continues to grow and evolve rapidly in recent years with the increasing consumer demand from food systems to support their health and well-being. In addition, there is an increase in the number of digital tools in the research phase to calculate the nutrition requirement, scan the food based on appearance and help the individuals monitor their nutrition intake. This will further revolutionize the U.S. clinical nutrition market in the future.

Increasing Demand For The Infant Nutrition
One of the significant concerns in infants and toddlers arising rapidly in the US is the low-weight birth rate. About one in 12 babies is born with a low birth rate in the US. Increasing infant birth rates with lower weight delivers significant industry growth opportunities in milk-based nutritional products for U.S. clinical nutrition market players. Milk-based nutritional products are not new in the industry, but increasing demand and high competition among the industry players resulted in innovative product deliveries in recent years.

In 2021, the North American Based Organization Nutricia (by Danone) got approval for the new infant nutrition product Fortini from US FDA. This product is developed to support children living with the risk of growth deficiencies and those with increased energy requirements.

SEGMENTATION ANALYSIS

INSIGHTS BY ROUTE OF ADMINISTRATION
The U.S. clinical nutrition market by route of administration is segmented into oral, enteral, and parenteral, of which the oral segment dominated the industry with a higher share in 2021; due to the higher preference. At homecare, the oral route of administering clinical nutrition solutions is highly preferred among the pediatric population. The oral route of administration accounted for a higher 45.51% industry share.

In 2021, the enteral segment showed dominance over the parenteral segment, with a 36.36% share in the U.S. clinical nutrition market. Enteral nutrition is one of the vital parts of nutrition therapy when the patient cannot meet the nutritional demand by oral intervention. Enteral nutrition is commonly delivered from pediatric to geriatric populations when the patient suffers from gastrointestinal disease.

INSIGHTS BY PRODUCT

The U.S. clinical nutrition market is segmented into powder, liquid, and semi-solid under the products segment. In 2021, the powder product segment accounted for approx. 52% of the U.S. clinical nutrition market share. The high adoption, new product innovation, and higher recommendation by professionals drive significant segmental growth and dominate the other two segments with higher industry share.

The liquid segment in the U.S. clinical nutrition market was valued at USD 3.08 billion in 2021. Liquid form clinical nutrition products deliver enteral and parenteral nutrition therapy. Ready-to-drink is a significant category in the liquid form clinical nutrition product category and is trending in the industry. Their increasing energy drink use in sports and physical activities and rapid energy boosting accelerate high segmental growth.

INSIGHTS BY AGE GROUP
By age group, the infant and toddlers segment shows lucrative opportunities and is growing at a CAGR of 6.61% during the forecast period. The infant and toddler population is a rapidly growing segment in the U.S. clinical nutrition market. Further, the child and teenage segment accounted for a 30.83% industry share and dominated the other segments.

Opportunities for Industry Growth in the US by Child & Teenage 2021

  • In the US high-school students, only 9% meet the daily fruit intake recommendations remaining are some who consume fruits or very low consumption.
  • Only 2% of US children adopt and stick to the recommended vegetable guidelines.
  • The higher consumption of added sugar and unhealthy daily eating habits accounted for children and teenage (2 to 19 age) up to 16% of their total daily calories.

INSIGHTS BY APPLICATION
Malnutrition is one of the major concerns addressed in the US population. Due to the increasing prevalence of various chronic conditions such as obesity/overweight, diabetes, hypertension, GI disorders, CVD, and others led to malnutrition in hospitalized as well as the general population and demand for clinical nutrition. In 2021, the malnutrition segment accounted for a 42.01% higher U.S. clinical nutrition market share and dominated other segments. Currently, more than 40 million US people and around 12 million children are food insure. Many US-based families face poverty and hunger challenges in areas where unprocessed and fresh healthy food is unavailable or sometimes expensive.

Cancer patients are likely to lose weight due to less eating due to stress, pain, diagnosis and treatments, nausea, and test change. Cancer-related malnutrition affects one out of three cancer patients. The U.S. clinical nutrition market by cancer is growing at a CAGR of 6.96% during the forecast period. The demand for good nutrition is significant if the person has cancer due to its illness, and treatments can impact food consumption. Also, cancer treatments impact how the body tolerates certain foods and uses nutrients. If that severe condition appears in the patients, professionals recommend clinical nutrition to the patients and deliver care.

INSIGHTS BY DISTRIBUTION CHANNEL
The U.S. clinical nutrition market by distribution channels is segmented into institutional sales channels, supermarkets and hypermarkets, pharmacies and drug stores, specialty stores, and online sales channels. In 2021, the institutional sales segment accounted for 45.53% industry share in the clinical nutrition market in the US. Institutional sales channels are emerging distribution channels for the clinical nutrition industry, which differ entirely from healthcare practitioner distribution channels. Some industry players came up with unique distribution channels to eliminate the delay and third-party interference in the supply of products.

The supermarket & hypermarket U.S. clinical nutrition market was valued at USD 2.07 billion in 2021. For clinical nutrition, supermarkets and hypermarket are large retail stores operated by self-services that offer milk-based formulas, energy drinks, ready-to-drink, and other clinical nutrition and dietary products recommended by professionals. On the other side, the hypermarket plays a vital role in clinical nutrition products sale. It is one-stop shopping where most of the required clinical nutrition products are available in large amounts, so small retailers or customers can buy them and drive the sale.

INSIGHTS BY END-USER
With the increasing prevalence of malnutrition, metabolic disorders, cancer, GI disorders, and other medical conditions, the hospitalization rate also increased in the US. Hospitals play a vital role in oral, enteral, and parenteral clinical nutrition therapies and contribute to higher industry growth under the end-user segment. In 2021, hospital segments accounted for a 41.95% U.S. clinical nutrition market share. The increasing number of hospital stays led to a rising rate of malnutrition. In the US, millions of people have hospital stays annually and account for malnutrition care which significantly drives the adoption of clinical nutrition therapies in hospitals. The significant demand for oral nutrition supplements (ONS), specifically developed for energy, protein, and other nutrient delivery propels the significant segmental growth.

Homecare is one of the trending healthcare settings widely accepted in the US. After the emergence of the COVID-19 pandemic, most ICU patients and hospitalized patients prefer home nutrition therapies due to their benefits and keep matter with their comfort. Home care nutrition therapies give patients the best environment, showing the rapid recovery of chronically ill patients—the availability of home enteral and parenteral clinical nutrition therapy providers in the US fuel the industry's growth. The homecare U.S. clinical nutrition market is growing at a CAGR of 5.86% during the forecast period.

VENDOR LANDSCAPE

Abbott, B. Braun Melsungen Ag, Baxter, Danone, Fresenius Kabi, Nestle, Perrigo Company, and Reckitt Benckiser Group are the leading players in the U.S. clinical nutrition market players, accounting for the higher industry share in the United States. On the other hand, emerging players and new start-ups are trying to achieve a solid customer base and market expansion. The presence of emerging industry players positively influences the competition in the clinical nutrition market in the US. The primary competition among the industry players accounted due to new product launches, emerging, and gold standard formulations.

Competition Among the Major Industry Players

  • Abbott’s Ensure is one of the leading clinical nutrition products used in the U.S. clinical nutrition market. This product significantly drives the company's high customer base and delivers higher revenue yearly.
  • Danone is a leading industry player offering specialized nutrition comprising Advanced Medical Nutrition (AMN) and Early Life Nutrition solutions.
  • Perrigo Company is one of the leading companies offering store-brand self-care products, including toddler and infant formulas and pediatric and adult nutrition drinks.

Frequently Asked Questions

What is the size of the U.S. clinical nutrition market?

The U.S. clinical nutrition market size was valued at USD 12.07 billion in 2021 and is expected to reach USD 16.63 billion by 2027. The innovation in personalized and targeted clinical nutrition solutions delivers new growth opportunities in the U.S. clinical nutrition market.

What is the projected growth rate of the U.S. clinical nutrition market?

The U.S. clinical nutrition market share is expected to grow at a CAGR of 5.49% from 2022 to 2027.

What are the trends in the U.S. clinical nutrition market?

Innovation in Personalization and Targeted Solutions, Increasing Demand for Infant Nutrition, Advancement in Nutritional Therapies, and Shift Towards Home Nutritional Care are the significant trends in the U.S. clinical nutrition market.

Who are the key players in the U.S. clinical nutrition market?

Abbott, B. Braun Melsungen Ag., Baxter, Danone, Fresenius Kabi, Nestle, Perrigo Company, and Reckitt Benckiser Group are the leading U.S. clinical nutrition market companies.

Which product segment is expected to dominate the U.S. clinical nutrition market?

The powder segment accounted for 51.99% U.S. clinical nutrition market share and dominated the product segment.

The U.S. clinical nutrition market is expected to grow at a CAGR of approximately 5.49% from 2021 to 2027.

The following factors are likely to contribute to the growth of the U.S. clinical nutrition market during the forecast period:

  • Government Initiatives, Investments, And Funding for Clinical Nutrition Research
  • Increasing Chronic Diseases Prevalence Required Nutritional Support
  • Impact of COVID-19 On Clinical Nutrition

Base Year: 2021

Forecast Year: 2022-2027

The report considers the present scenario of the U.S. clinical nutrition market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the market.

Key Vendors

  • Abbott
    • Business Overview
    • Product Offerings
    • Key Strategies
    • Key Strengths
    • Key Opportunities
  • B. Braun Melsungen Ag.
  • Baxter
  • Danone
  • Fresenius Kabi
  • Nestle
  • Perrigo Company
  • Reckitt Benckiser Group

Other Prominent Vendors

  • ADM
    • Business Overview
    • Product Offerings
  • Ajinomoto Co
  • BASF SE
  • DSM
  • Envara Health
  • Glanbia plc
  • Hero Nutritionals
  • Hum Nutrition
  • Kendal Nutricare
  • Lonza
  • Lactalis Nutrition Santé
  • MEND
  • MediFood International SA
  • Primus Pharmaceuticals
  • SternLife GmbH & Co. KG
  • The Craft Heinz Company
  • Vivante Health

Segmentation by Products

  • Powder
  • Liquid
  • Semi-solid

Segmentation by Route of Administration

  • Oral
  • Enteral nutrition
  • Parenteral Nutrition

Segmentation by Age Group

  • Infant & Toddler
  • Children and teenagers
  • Adult
  • Geriatric

Segmentation by Application

  • Malnutrition
  • Metabolic Disorders
  • Gastrointestinal disorders (GI)
  • Cancer
  • Others

Segmentation by Distribution Channels

  • Institutional Sales Channels
  • Supermarkets and Hypermarkets
  • Pharmacies and Drug Stores
  • Specialty Stores
  • Online Channels
  • Others

Segmentation by End-Users

  • Hospitals
  • Individuals
  • Home care
  • Long-term care facilities

EXHIBIT 1 SEGMENTATION OF CLINICAL NUTRITION MARKET IN US

EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021

EXHIBIT 3 US HEALTH CONDITIONS AND STATISTICS 2020

EXHIBIT 4 CLINICAL NUTRITION MARKET IN US: TRENDS & DRIVERS

EXHIBIT 5 CLINICAL NUTRITION MARKET IN US: SEGMENTATION

EXHIBIT 6 IMPACT OF INNOVATION IN PERSONALIZATION AND TARGETED SOLUTIONS

EXHIBIT 7 TARGETED NUTRITION TYPES AND BENEFITS

EXHIBIT 8 INCREASING DEMAND FOR INFANT NUTRITION

EXHIBIT 9 PREVALENCE OF INFANTS WITH LOW BIRTH WEIGHT 200-2022 (%)

EXHIBIT 10 PERCENTAGE OF BABIES BORN LOW BIRTHWEIGHT BY STATES IN US (2020)

EXHIBIT 11 BIRTHWEIGHT & GESTATION STATISTICS IN US (2020)

EXHIBIT 12 IMPACT OF ADVANCES IN NUTRITIONAL THERAPIES

EXHIBIT 13 NOVEL FORMULATION: TRANSFORMATIVE INNOVATIONS

EXHIBIT 14 IMPACT OF SHIFT TOWARD HOME NUTRITIONAL CARE

EXHIBIT 15 HOME NUTRITION DRIVING FACTOR BY PARENTERAL & ENTERAL NUTRITION

EXHIBIT 16 IMPACT OF GOVERNMENT INITIATIVES INVESTMENTS AND FUNDING FOR CLINICAL NUTRITION RESEARCH

EXHIBIT 17 US GOVERNMENT DEPARTMENTS & AGENCIES ENGAGED IN COUNTRIES NUTRITION ENHANCEMENT

EXHIBIT 18 CONGRESSIONAL NUTRITION FUNDING COMPARED TO NUMBER OF CHILDREN STUNTED 2010-2019

EXHIBIT 19 IMPACT OF INCREASING CHRONIC DISEASES PREVALENCE REQUIRES NUTRITIONAL SUPPORT

EXHIBIT 20 US HOUSEHOLDS BY FOOD SECURITY STATUS 2020 (%)

EXHIBIT 21 US PREVALENCE OF STUNTING WASTING AND OVERWEIGHT CONDITIONS AMONG CHILDREN (5 YEARS OF AGE) (2000-2018)

EXHIBIT 22 IMPACT OF COVID-19 ON CLINICAL NUTRITION

EXHIBIT 23 IMPACT OF SIDE EFFECTS AND COMPLICATIONS DUE TO CLINICAL NUTRITION

EXHIBIT 24 DRAWBACKS OF CLINICAL NUTRITION

EXHIBIT 25 IMPACT OF BARRIERS TO DELIVERING ENTERAL NUTRITION IN PEDIATRIC ICU

EXHIBIT 26 IMPACT OF HIGH COST OF CLINICAL NUTRITION

EXHIBIT 27 CLINICAL NUTRITION MARKET IN US: MARKET SEGMENTATION

EXHIBIT 28 CLINICAL NUTRITION MARKET IN US BY PRODUCT

EXHIBIT 29 CLINICAL NUTRITION MARKET IN US BY PRODUCT

EXHIBIT 30 CLINICAL NUTRITION MARKET IN US BY APPLICATION

EXHIBIT 31 CLINICAL NUTRITION MARKET IN US BY AGE GROUP

EXHIBIT 32 CLINICAL NUTRITION MARKET IN US BY DISTRIBUTION CHANNEL

EXHIBIT 33 CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)

EXHIBIT 34 FIVE FORCES ANALYSIS 2021

EXHIBIT 35 INCREMENTAL GROWTH BY ROUTE OF ADMINISTRATION 2021 & 2027

EXHIBIT 36 CLINICAL NUTRITION MARKET IN US BY ROUTE OF ADMINISTRATION 2021-2027

EXHIBIT 37 CLINICAL NUTRITION MARKET IN US BY ROUTE OF ADMINISTRATION: OVERVIEW

EXHIBIT 38 CLINICAL NUTRITION MARKET IN US BY ROUTE OF ADMINISTRATION: INCREMENTAL GROWTH

EXHIBIT 39 CLINICAL NUTRITION MARKET IN US BY ROUTE OF ADMINISTRATION: ABSOLUTE GROWTH

EXHIBIT 40 ORAL CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 41 ORAL CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)

EXHIBIT 42 ENTERAL CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 43 ENTERAL CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)

EXHIBIT 44 PARENTERAL CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 45 PARENTERAL CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)

EXHIBIT 46 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 47 CLINICAL NUTRITION MARKET IN US BY PRODUCT 2021-2027

EXHIBIT 48 CLINICAL NUTRITION MARKET IN US BY PRODUCT: OVERVIEW

EXHIBIT 49 CLINICAL NUTRITION MARKET IN US BY PRODUCT: INCREMENTAL GROWTH

EXHIBIT 50 CLINICAL NUTRITION MARKET IN US BY PRODUCT: ABSOLUTE GROWTH

EXHIBIT 51 POWDER CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 52 POWDER CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)

EXHIBIT 53 LIQUID CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 54 LIQUID CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)

EXHIBIT 55 SEMI-SOLID ORAL NUTRITIONAL SUPPLEMENTS FOR VARIOUS CLINICAL INDICATIONS

EXHIBIT 56 SEMI-SOLID CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 57 SEMI-SOLID CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)

EXHIBIT 58 INCREMENTAL GROWTH BY AGE GROUP 2021 & 2027

EXHIBIT 59 CLINICAL NUTRITION MARKET IN US BY AGE GROUP 2021-2027

EXHIBIT 60 CLINICAL NUTRITION MARKET IN US BY AGE GROUP: OVERVIEW

EXHIBIT 61 CLINICAL NUTRITION MARKET IN US BY AGE GROUP: INCREMENTAL GROWTH

EXHIBIT 62 CLINICAL NUTRITION MARKET IN US BY AGE GROUP: ABSOLUTE GROWTH

EXHIBIT 63 US TEEN DEMOGRAPHICS IN 2021

EXHIBIT 64 OBESITY PREVALENCE AMONG US CHILDREN & TEENAGE FROM 1970 TO 2022

EXHIBIT 65 CHILD & TEENAGER CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 66 CHILD & TEENAGER CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)

EXHIBIT 67 ADULT CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 68 ADULT CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)

EXHIBIT 69 US: INSTITUTIONAL MANAGEMENT SUB-DOMAIN SCORE FOR MATERNITY PRACTICES IN INFANT NUTRITION AND CARE BY STATE 2018

EXHIBIT 70 INFANT & TODDLER CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 71 INFANT & TODDLER CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)

EXHIBIT 72 CHILD & TEENAGER CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 73 OBESITY PREVALENCE AMONG GERIATRIC POPULATION IN US IN 2010 (%)

EXHIBIT 74 GERIATRIC CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)

EXHIBIT 75 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 76 CLINICAL NUTRITION MARKET IN US BY APPLICATION 2021-2027

EXHIBIT 77 CLINICAL NUTRITION MARKET IN US BY APPLICATION OVERVIEW

EXHIBIT 78 CLINICAL NUTRITION MARKET IN US BY APPLICATION: INCREMENTAL GROWTH

EXHIBIT 79 CLINICAL NUTRITION MARKET IN US BY APPLICATION: ABSOLUTE GROWTH

EXHIBIT 80 US HUNGER STATISTICS 2020

EXHIBIT 81 CLINICAL NUTRITION MARKET IN US BY MALNUTRITION: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 82 TOP TEN HUNGRIEST STATES IN US

EXHIBIT 83 MALNUTRITION CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)

EXHIBIT 84 SOME COMMON METABOLIC DISORDERS

EXHIBIT 85 METABOLIC DISORDERS CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 86 METABOLIC DISORDERS CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)

EXHIBIT 87 CLINICAL NUTRITION MARKET IN US BY GASTROINTESTINAL DISORDER: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 88 CLINICAL NUTRITION MARKET IN US BY GASTROINTESTINAL DISEASES 2021–2027 ($ BILLION)

EXHIBIT 89 NEW CANCER CASES: FACTS & STATISTICS IN US (2020)

EXHIBIT 90 STRUCTURE OF ESPEN PRACTICAL GUIDELINES: CLINICAL NUTRITION IN CANCER

EXHIBIT 91 CLINICAL NUTRITION MARKET IN US BY CANCER: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 92 CLINICAL NUTRITION MARKET IN US BY CANCER 2021–2027 ($ BILLION)

EXHIBIT 93 US CARDIOVASCULAR DISEASES RISK FACTOR INCREASE BETWEEN 2025 AND 2060

EXHIBIT 94 OTHER APPLICATION CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 95 OTHERS APPLICATION CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)

EXHIBIT 96 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027

EXHIBIT 97 CLINICAL NUTRITION MARKET IN US BY DISTRIBUTION CHANNELS 2021-2027

EXHIBIT 98 CLINICAL NUTRITION MARKET IN US BY DISTRIBUTION CHANNELS: OVERVIEW

EXHIBIT 99 CLINICAL NUTRITION MARKET IN US BY DISTRIBUTION CHANNELS: INCREMENTAL GROWTH

EXHIBIT 100 CLINICAL NUTRITION MARKET IN US BY DISTRIBUTION CHANNELS: ABSOLUTE GROWTH

EXHIBIT 101 INSTITUTIONAL SALES CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 102 INSTITUTIONAL SALES CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)

EXHIBIT 103 SUPERMARKET & HYPERMARKET CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 104 SUPERMARKET & HYPERMARKET CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)

EXHIBIT 105 US E-COMMERCE SALES ($ BILLION)

EXHIBIT 106 ONLINE CHANNELS CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 107 ONLINE DISTRIBUTION CHANNELS CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)

EXHIBIT 108 PHARMACIES & DRUG STORES CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 109 PHARMACIES AND DRUG STORES CLINICAL NUTRITION MARKET IN US. 2021–2027 ($ BILLION)

EXHIBIT 110 SPECIALTY STORES CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)

EXHIBIT 111 SPECIALTY STORES CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 112 CLINICAL NUTRITION MARKET IN US BY OTHER DISTRIBUTION CHANNEL: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 113 OTHERS DISTRIBUTION CHANNELS CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)

EXHIBIT 114 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 115 CLINICAL NUTRITION MARKET IN US BY END-USER 2021-2027

EXHIBIT 116 CLINICAL NUTRITION MARKET IN US BY END-USER: OVERVIEW

EXHIBIT 117 CLINICAL NUTRITION MARKET IN US BY END-USER: INCREMENTAL GROWTH

EXHIBIT 118 CLINICAL NUTRITION MARKET IN US BY END-USER: ABSOLUTE GROWTH

EXHIBIT 119 HOSPITALS STAY IN US & MALNUTRITION 2018

EXHIBIT 120 HOSPITALS CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 121 HOSPITALS CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)

EXHIBIT 122 INDIVIDUAL CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 123 INDIVIDUAL CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)

EXHIBIT 124 HOMECARE CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 125 HOMECARE CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)

EXHIBIT 126 LONG-TERM CARE CENTERS CLINICAL NUTRITION MARKET IN US: INCREMENTAL AND ABSOLUTE GROWTH

EXHIBIT 127 LONG-TERM CARE CENTERS CLINICAL NUTRITION MARKET IN US 2021–2027 ($ BILLION)

EXHIBIT 128 VENDORS OFFERING CLINICAL NUTRITION MARKET: CAPABILITIES & EXPERTISE ASSESSMENT

EXHIBIT 129 VENDORS OFFERING CLINICAL NUTRITION: MARKET DOMINANCE ANALYSIS

EXHIBIT 130 ABBOTT: ANNUAL REVENUE 2019-2021 ($ MILLION)

EXHIBIT 131 B. BRAUN MELSUNGEN REVENUE 2019-2021 ($ MILLION)

EXHIBIT 132 BAXTER: ANNUAL REVENUE 2019-2021 ($ MILLION)

EXHIBIT 133 BAXTER: ANNUAL REVENUE BY CLINICAL NUTRITION 2019-2021 ($ MILLION)

EXHIBIT 134 DANONE: REVENUE BY BUSINESS SEGMENT IN 2021 (%)

EXHIBIT 135 DANONE: REVENUE BY GEOGRAPHY IN 2021 (%)

EXHIBIT 136 DANONE: ANNUAL REVENUE 2019-2021 ($ BILLION)

EXHIBIT 137 FRESENIUS KABI: REVENUE 2019-2021 ($ BILLION)

EXHIBIT 138 FRESENIUS KABI SALES BY GEOGRAPHY 2021 (%)

EXHIBIT 139 FRESENIUS KABI SALES BY SEGMENT 2021 (%)

EXHIBIT 140 PERRIGO COMPANY. ANNUAL REVENUE 2019-2021 ($ MILLION)

EXHIBIT 141 PERRIGO COMPANY REVENUE BY NUTRITION SEGMENT 2021 ($ MILLION)

EXHIBIT 142 RECKITT BENCKISER GROUP ANNUAL REVENUE 2019-2021 ($ BILLION)

EXHIBIT 143 RECKITT BENCKISER GROUP REVENUE BY NUTRITION BUSINESS SEGMENT 2019-2021 ($ MILLION)

 

LIST OF TABLES

TABLE 1 KEY CAVEATS

TABLE 2 CURRENCY CONVERSION 2015−2021

TABLE 3 ENTERAL FEEDING BARRIERS IN PEDIATRIC ICU

TABLE 4 SOME OF ORAL NUTRITION SOLUTIONS IN US CLINICAL NUTRITION MARKET

TABLE 5 ORAL CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION 2021−2027 ($ BILLION)

TABLE 6 ORAL CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION 2021−2027 (%)

TABLE 7 ENTERAL US CLINICAL NUTRITION MARKET BY AGE GROUP 2021−2027 ($ BILLION)

TABLE 8 ENTERAL CLINICAL NUTRITIONAL MARKET BY AGE GROUP 2021−2027 (%)

TABLE 9 PARENTERAL CLINICAL NUTRITION MARKET BY AGE GROUP 2021−2027 ($ BILLION)

TABLE 10 PARENTERAL CLINICAL NUTRITION MARKET BY AGE GROUP 2021−2027 (%)

TABLE 11 POWDER FORM LEADING CLINICAL NUTRITION PRODUCTS

TABLE 12 FACTS ABOUT NUTRITION-RELATED HEALTH CONDITIONS IN US ADULT POPULATION -2020

TABLE 13 BREASTFEEDING RATE IN US IN 2020

TABLE 14 ABBOTT: MAJOR PRODUCT OFFERINGS

TABLE 15 B. BRAUN MELSUNGEN AG: MAJOR PRODUCT OFFERINGS

TABLE 16 BAXTER: MAJOR PRODUCT OFFERINGS

TABLE 17 DANONE: MAJOR PRODUCT OFFERINGS

TABLE 18 FRESENIUS KABI: MAJOR PRODUCT OFFERINGS

TABLE 19 NESTLE: MAJOR PRODUCT OFFERINGS

TABLE 20 PERRIGO COMPANY: MAJOR PRODUCT OFFERINGS

TABLE 21 RECKITT BENCKISER GROUP: MAJOR PRODUCT OFFERINGS

TABLE 22 ADM: MAJOR PRODUCT OFFERINGS

TABLE 23 AJINOMOTO CO: MAJOR PRODUCT OFFERINGS

TABLE 24 BASF SE: MAJOR PRODUCT OFFERINGS

TABLE 25 DSM: MAJOR PRODUCT OFFERINGS

TABLE 26 ENVARA HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 27 GLANBIA (GLANBIA NUTRITIONALS): MAJOR PRODUCT OFFERINGS

TABLE 28 HERO NUTRITIONALS: MAJOR PRODUCT OFFERINGS

TABLE 29 HUM NUTRITION: MAJOR PRODUCT OFFERINGS

TABLE 30 KENDAL NUTRICARE: MAJOR PRODUCT OFFERINGS

TABLE 31 LONZA: MAJOR PRODUCT OFFERINGS

TABLE 32 LACTALIS NUTRITION SANTÉ: MAJOR PRODUCT OFFERINGS

TABLE 33 MEND: MAJOR PRODUCT OFFERINGS

TABLE 34 MEDIFOOD INTERNATIONAL SA: MAJOR PRODUCT OFFERINGS

TABLE 35 PRIMUS PHARMACEUTICALS: MAJOR PRODUCT OFFERINGS

TABLE 36 STERNLIFE GMBH & CO. KG: MAJOR PRODUCT OFFERINGS

TABLE 37 THE CRAFT HEINZ COMPANY: MAJOR PRODUCT OFFERINGS

TABLE 38 VIVANTE HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 39 CLINICAL NUTRITION MARKET IN US BY PRODUCT 2021−2027 ($ BILLION)

TABLE 40 CLINICAL NUTRITION MARKET IN US BY PRODUCT 2021−2027 (%)

TABLE 41 CLINICAL NUTRITION MARKET IN US BY ROUTE OF ADMINISTRATION 2021−2027 ($ BILLION)

TABLE 42 CLINICAL NUTRITION MARKET IN US BY ROUTE OF ADMINISTRATION 2021−2027 (%)

TABLE 43 CLINICAL NUTRITION MARKET IN US BY AGE GROUP 2021−2027 ($ BILLION)

TABLE 44 CLINICAL NUTRITION MARKET IN US BY AGE GROUP 2021-2027 (%)

TABLE 45 CLINICAL NUTRITION MARKET IN US BY APPLICATION 2021−2027 ($ BILLION)

TABLE 46 CLINICAL NUTRITION MARKET IN US BY APPLICATION 2021−2027 (%)

TABLE 47 CLINICAL NUTRITION MARKET IN US BY DISTRIBUTION CHANNELS 2021−2027 ($ BILLION)

TABLE 48 CLINICAL NUTRITION MARKET IN US BY DISTRIBUTION CHANNELS 2021−2027 (%)

TABLE 49 CLINICAL NUTRITION MARKET IN US BY END-USERS 2021−2027 ($ BILLION)

TABLE 50 CLINICAL NUTRITION MARKET IN US BY END-USERS 2021−2027 (%)

TABLE 51 ORAL CLINICAL NUTRITION MARKET IN US BY AGE GROUP 2021−2027 ($ BILLION)

TABLE 52 ORAL CLINICAL NUTRITION MARKET IN US BY AGE GROUP 2021-2027 (%)

TABLE 53 ENTERAL CLINICAL NUTRITION MARKET IN US BY AGE GROUP 2021−2027 ($ BILLION)

TABLE 54 ENTERAL CLINICAL NUTRITION MARKET IN US BY AGE GROUP 2021-2027 (%)

TABLE 55 PARENTERAL CLINICAL NUTRITION MARKET IN US BY AGE GROUP 2021−2027 ($ BILLION)

TABLE 56 PARENTERAL CLINICAL NUTRITION MARKET IN US BY AGE GROUP 2021-2027 (%)

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

 

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 EXCLUSIONS

4.1.3 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.1 MARKET SEGMENTATION BY PRODUCTS

4.3.2 MARKET SEGMENTATION BY ROUTE OF ADMINISTRATION

4.3.3 MARKET SEGMENTATION BY AGE GROUP

4.3.4 MARKET SEGMENTATION BY APPLICATION

4.3.5 MARKET SEGMENTATION BY DISTRIBUTION CHANNELS

4.3.6 MARKET SEGMENTATION BY END-USERS

 

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

 

6 MARKET AT A GLANCE

7 INTRODUCTION

7.1 OVERVIEW

 

8 PREMIUM INSIGHTS

9 MARKET OPPORTUNITIES & TRENDS

9.1 INNOVATION IN PERSONALIZATION AND TARGETED SOLUTIONS

9.2 INCREASING DEMAND FOR INFANT NUTRITION

9.3 ADVANCES IN NUTRITIONAL THERAPIES

9.4 SHIFT TOWARD HOME NUTRITIONAL CARE

 

10 MARKET GROWTH ENABLERS

10.1 GOVERNMENT INITIATIVES, INVESTMENTS, AND FUNDING FOR CLINICAL NUTRITION RESEARCH

10.2 INCREASING CHRONIC DISEASE PREVALENCE REQUIRES NUTRITIONAL SUPPORT

10.3 IMPACT OF COVID-19 ON CLINICAL NUTRITION

 

11 MARKET RESTRAINTS

11.1 SIDE EFFECTS AND COMPLICATIONS DUE TO CLINICAL NUTRITION

11.2 BARRIERS TO DELIVERING ENTERAL NUTRITION IN PEDIATRIC ICU

11.3 HIGH COST OF CLINICAL NUTRITION

 

12 MARKET LANDSCAPE

12.1 MARKET OVERVIEW

12.1.1 CLINICAL NUTRITION MARKET IN US: PRODUCT SEGMENTATION INSIGHTS

12.1.2 CLINICAL NUTRITION MARKET IN US: PRODUCT SEGMENTATION INSIGHTS

12.1.3 CLINICAL NUTRITION MARKET IN US BY APPLICATION

12.1.4 CLINICAL NUTRITION MARKET IN US BY AGE GROUP

12.1.5 CLINICAL NUTRITION MARKET IN US BY DISTRIBUTION CHANNEL

12.1.6 CLINICAL NUTRITION MARKET IN US BY END-USER

12.2 MARKET SIZE & FORECAST

12.3 FIVE FORCES ANALYSIS

12.3.1 THREAT OF NEW ENTRANTS

12.3.2 BARGAINING POWER OF SUPPLIERS

12.3.3 BARGAINING POWER OF BUYERS

12.3.4 THREAT OF SUBSTITUTES

12.3.5 COMPETITIVE RIVALRY

 

13 ROUTE OF ADMINISTRATION

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

13.3 ORAL

13.3.1 MARKET OVERVIEW

13.3.2 MARKET SIZE & FORECAST

13.3.3 ORAL PRODUCT MARKET BY ROUTE OF ADMINISTRATION

13.4 ENTERAL

13.4.1 MARKET OVERVIEW

13.4.2 MARKET SIZE & FORECAST

13.4.3 ENTERAL PRODUCT MARKET BY AGE GROUP

13.5 PARENTERAL

13.5.1 MARKET OVERVIEW

13.5.2 MARKET SIZE & FORECAST

13.5.3 PARENTERAL PRODUCT MARKET BY AGE GROUP

 

14 PRODUCT

14.1 MARKET SNAPSHOT & GROWTH ENGINE

14.2 MARKET OVERVIEW

14.3 POWDER

14.3.1 MARKET OVERVIEW

14.3.2 MARKET SIZE & FORECAST

14.4 LIQUID

14.4.1 MARKET OVERVIEW

14.4.2 MARKET SIZE & FORECAST

14.5 SEMI-SOLID

14.5.1 MARKET OVERVIEW

14.5.2 MARKET SIZE & FORECAST

 

15 AGE GROUP

15.1 MARKET SNAPSHOT & GROWTH ENGINE

15.2 MARKET OVERVIEW

15.3 CHILD AND TEENAGER

15.3.1 MARKET OVERVIEW

15.3.2 MARKET SIZE & FORECAST

15.4 ADULT

15.4.1 MARKET OVERVIEW

15.4.2 MARKET SIZE & FORECAST

15.5 INFANT & TODDLER

15.5.1 MARKET OVERVIEW

15.5.2 MARKET SIZE & FORECAST

15.6 GERIATRIC

15.6.1 MARKET OVERVIEW

15.6.2 MARKET SIZE & FORECAST

 

16 APPLICATION

16.1 MARKET SNAPSHOT & GROWTH ENGINE

16.2 MARKET OVERVIEW

16.3 MALNUTRITION

16.3.1 MARKET OVERVIEW

16.3.2 MARKET SIZE & FORECAST

16.4 METABOLIC DISORDERS

16.4.1 MARKET OVERVIEW

16.4.2 MARKET SIZE & FORECAST

16.5 GASTROINTESTINAL DISEASES

16.5.1 MARKET OVERVIEW

16.5.2 MARKET SIZE & FORECAST

16.6 CANCER

16.6.1 MARKET OVERVIEW

16.6.2 MARKET SIZE & FORECAST

16.7 OTHERS

16.7.1 MARKET OVERVIEW

16.7.2 MARKET SIZE & FORECAST

 

17 DISTRIBUTION CHANNEL

17.1 MARKET SNAPSHOT & GROWTH ENGINE

17.2 MARKET OVERVIEW

17.3 INSTITUTIONAL SALES

17.3.1 MARKET OVERVIEW

17.3.2 MARKET SIZE & FORECAST

17.4 SUPERMARKET & HYPERMARKET

17.4.1 MARKET OVERVIEW

17.4.2 MARKET SIZE & FORECAST

17.5 ONLINE CHANNELS

17.5.1 MARKET OVERVIEW

17.5.2 MARKET SIZE & FORECAST

17.6 PHARMACIES & DRUG STORES

17.6.1 MARKET OVERVIEW

17.6.2 MARKET SIZE & FORECAST

17.7 SPECIALTY STORES

17.7.1 MARKET OVERVIEW

17.7.2 MARKET SIZE & FORECAST

17.8 OTHERS

17.8.1 MARKET OVERVIEW

17.8.2 MARKET SIZE & FORECAST

 

18 END-USER

18.1 MARKET SNAPSHOT & GROWTH ENGINE

18.2 MARKET OVERVIEW

18.3 HOSPITALS

18.3.1 MARKET OVERVIEW

18.3.2 MARKET SIZE & FORECAST

18.4 INDIVIDUAL

18.4.1 MARKET OVERVIEW

18.4.2 MARKET SIZE & FORECAST

18.5 HOMECARE

18.5.1 MARKET OVERVIEW

18.5.2 MARKET SIZE & FORECAST

18.6 LONG-TERM CARE CENTERS

18.6.1 MARKET OVERVIEW

18.6.2 MARKET SIZE & FORECAST

 

19 COMPETITIVE LANDSCAPE

19.1 COMPETITION OVERVIEW

19.2 MARKET SHARE ANALYSIS

19.2.1 ABBOTT

19.2.2 B. BRAUN MELSUNGEN AG

19.2.3 BAXTER

19.2.4 DANONE

19.2.5 FRESENIUS KABI

19.2.6 NESTLE

19.2.7 PERRIGO COMPANY

19.2.8 RECKITT BENCKISER

 

20 KEY COMPANY PROFILES

20.1 ABBOTT

20.1.1 BUSINESS OVERVIEW

20.1.2 PRODUCT OFFERINGS

20.1.3 KEY STRATEGIES

20.1.4 KEY STRENGTHS

20.1.5 KEY OPPORTUNITIES

20.2 B. BRAUN MELSUNGEN AG

20.2.1 BUSINESS OVERVIEW

20.2.2 PRODUCT OFFERINGS

20.2.3 KEY STRATEGIES

20.2.4 KEY STRENGTHS

20.2.5 KEY OPPORTUNITIES

20.3 BAXTER

20.3.1 BUSINESS OVERVIEW

20.3.2 PRODUCT OFFERINGS

20.3.3 KEY STRATEGIES

20.3.4 KEY STRENGTHS

20.3.5 KEY OPPORTUNITIES

20.4 DANONE

20.4.1 BUSINESS OVERVIEW

20.4.2 PRODUCT OFFERINGS

20.4.3 KEY STRATEGIES

20.4.4 KEY STRENGTHS

20.4.5 KEY OPPORTUNITIES

20.5 FRESENIUS KABI

20.5.1 BUSINESS OVERVIEW

20.5.2 PRODUCT OFFERINGS

20.5.3 KEY STRATEGIES

20.5.4 KEY STRENGTHS

20.5.5 KEY OPPORTUNITIES

20.6 NESTLE

20.6.1 BUSINESS OVERVIEW

20.6.2 PRODUCT OFFERINGS

20.6.3 KEY STRATEGIES

20.6.4 KEY STRENGTHS

20.6.5 KEY OPPORTUNITIES

20.7 PERRIGO COMPANY

20.7.1 BUSINESS OVERVIEW

20.7.2 PRODUCT OFFERINGS

20.7.3 KEY STRATEGIES

20.7.4 KEY STRENGTHS

20.7.5 KEY OPPORTUNITIES

20.8 RECKITT BENCKISER GROUP

20.8.1 BUSINESS OVERVIEW

20.8.2 PRODUCT OFFERINGS

20.8.3 KEY STRATEGIES

20.8.4 KEY STRENGTHS

20.8.5 KEY OPPORTUNITIES

 

21 OTHER PROMINENT VENDORS

21.1 ADM

21.1.1 BUSINESS OVERVIEW

21.1.2 PRODUCT OFFERINGS

21.2 AJINOMOTO CO

21.2.1 BUSINESS OVERVIEW

21.2.2 PRODUCT OFFERINGS

21.3 BASF SE

21.3.1 BUSINESS OVERVIEW

21.3.2 PRODUCT OFFERINGS

21.4 DSM

21.4.1 BUSINESS OVERVIEW

21.4.2 PRODUCT OFFERINGS

21.5 ENVARA HEALTH

21.5.1 BUSINESS OVERVIEW

21.5.2 PRODUCT OFFERINGS

21.6 GLANBIA PLC

21.6.1 BUSINESS OVERVIEW

21.6.2 PRODUCT OFFERINGS

21.7 HERO NUTRITIONALS

21.7.1 BUSINESS OVERVIEW

21.7.2 PRODUCT OFFERINGS

21.8 HUM NUTRITION

21.8.1 BUSINESS OVERVIEW

21.8.2 PRODUCT OFFERINGS

21.9 KENDAL NUTRICARE

21.9.1 BUSINESS OVERVIEW

21.9.2 PRODUCT OFFERINGS

21.10 LONZA

21.10.1 BUSINESS OVERVIEW

21.10.2 PRODUCT OFFERINGS

21.11 LACTALIS NUTRITION SANTÉ

21.11.1 BUSINESS OVERVIEW

21.11.2 PRODUCT OFFERINGS

21.12 MEND

21.12.1 BUSINESS OVERVIEW

21.12.2 PRODUCT OFFERINGS

21.13 MEDIFOOD INTERNATIONAL SA

21.13.1 BUSINESS OVERVIEW

21.13.2 PRODUCT OFFERINGS

21.14 PRIMUS PHARMACEUTICALS

21.14.1 BUSINESS OVERVIEW

21.14.2 PRODUCT OFFERINGS

21.15 STERNLIFE GMBH & CO. KG

21.15.1 BUSINESS OVERVIEW

21.15.2 PRODUCT OFFERINGS

21.16 THE CRAFT HEAINZ COMPANY

21.16.1 BUSINESS OVERVIEW

21.16.2 PRODUCT OFFERINGS

21.17 VIVANTE HEALTH

21.17.1 BUSINESS OVERVIEW

21.17.2 PRODUCT OFFERINGS

 

22 REPORT SUMMARY

22.1 KEY TAKEAWAYS

22.2 STRATEGIC RECOMMENDATIONS

 

23 QUANTITATIVE SUMMARY

23.1 MARKET BY PRODUCT

23.2 MARKET BY ROUTE OF ADMINISTRATION

23.3 MARKET BY AGE GROUP

23.4 MARKET BY APPLICATION

23.5 MARKET BY DISTRIBUTION CHANNEL

23.6 MARKET BY END-USERS

23.7 ROUTE OF ADMINISTRATION MARKET BY AGE GROUP

23.7.1 ORAL CLINICAL NUTRITION MARKET IN US BY AGE GROUP

23.7.2 ENTERAL CLINICAL NUTRITION MARKET IN US BY AGE GROUP

23.7.3 PARENTERAL CLINICAL NUTRITION MARKET IN US BY AGE GROUP

 

24 APPENDIX

24.1 ABBREVIATIONS

Select a license type that suits your business needs

Single User Licence

$3995.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email

5 User Licence

$4495.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Corporate Licence

$5495.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Datasheet Licence

$2000.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Frequently Asked Questions

What is the size of the U.S. clinical nutrition market?

The U.S. clinical nutrition market size was valued at USD 12.07 billion in 2021 and is expected to reach USD 16.63 billion by 2027. The innovation in personalized and targeted clinical nutrition solutions delivers new growth opportunities in the U.S. clinical nutrition market.

What is the projected growth rate of the U.S. clinical nutrition market?

The U.S. clinical nutrition market share is expected to grow at a CAGR of 5.49% from 2022 to 2027.

What are the trends in the U.S. clinical nutrition market?

Innovation in Personalization and Targeted Solutions, Increasing Demand for Infant Nutrition, Advancement in Nutritional Therapies, and Shift Towards Home Nutritional Care are the significant trends in the U.S. clinical nutrition market.

Who are the key players in the U.S. clinical nutrition market?

Abbott, B. Braun Melsungen Ag., Baxter, Danone, Fresenius Kabi, Nestle, Perrigo Company, and Reckitt Benckiser Group are the leading U.S. clinical nutrition market companies.

Which product segment is expected to dominate the U.S. clinical nutrition market?

The powder segment accounted for 51.99% U.S. clinical nutrition market share and dominated the product segment.